Analysis of Typical Problems of Moderate Change in Post-approval Chemical Drugs

被引：0
|
作者：
Yuan, Jianlong [1 ]
Zhang, Lingna [1 ]
Chen, Qingyu [1 ]
Huang, Rongzhen [1 ]
机构：
[1] Fujian Center for Drug Evaluation and Monitoring, Fuzhou,350003, China
来源：
Chinese Journal of Pharmaceuticals | 2023年 / 54卷 / 10期
关键词：
D O I：
10.16522/j.cnki.cjph.2023.10.017
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1517 / 1520
相关论文
共 50 条
  • [31] Analysis and Discussion of Common Problems in the Pre-approval Inspection of Heparin Drugs
    Hu, Xiaojuan
    Chinese Journal of Pharmaceuticals, 2023, 54 (04) : 617 - 621
  • [32] Analysis of the Regulatory Divergence of Comparative Dissolution Requirements for Post-Approval Manufacturing Changes of Modified Release Solid Oral Dosage Forms
    Langer, Connie
    Diaz, Dorys Argelia
    Van Alstine, Leslie
    Bandi, Nagesh
    Fitzgerald, Sarah
    Colgan, Stephen
    AAPS JOURNAL, 2020, 22 (01):
  • [33] Analysis of the Regulatory Divergence of Comparative Dissolution Requirements for Post-Approval Manufacturing Changes of Modified Release Solid Oral Dosage Forms
    Connie Langer
    Dorys Argelia Diaz
    Leslie Van Alstine
    Nagesh Bandi
    Sarah Fitzgerald
    Stephen Colgan
    The AAPS Journal, 22
  • [34] Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
    Moreira, G. F.
    Borchardt, I.
    Dias, F. C.
    Taveira, F. T.
    Pina, L. D. O.
    Rocha, W. M.
    Montella, T. C.
    de Melo, A. C.
    Ferreira, G. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1084 - S1085
  • [35] No change in avilamycin (Surmax® Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada
    Simjee, Shabbir
    Gould, George
    Maduro, Lila
    Boulianne, Martine
    Pridmore, Andrew
    Parent, Eric
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (05) : 1278 - 1281
  • [36] Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm
    Van Buskirk, Glenn A.
    Asotra, Satish
    Balducci, Christopher
    Basu, Prabir
    DiDonato, Gerald
    Dorantes, Angelica
    Eickhoff, W. Mark
    Ghosh, Tapash
    Gonzalez, Mario A.
    Henry, Theresa
    Howard, Matthew
    Kamm, Jason
    Laurenz, Steven
    MacKenzie, Ryan
    Mannion, Richard
    Noonan, Patrick K.
    Ocheltree, Terrance
    Pai, Umesh
    Poska, Richard P.
    Putnam, Michael L.
    Raghavan, Ramani R.
    Ruegger, Colleen
    Sanchez, Eric
    Shah, Vinod P.
    Shao, Zezhi Jesse
    Somma, Russell
    Tammara, Vijay
    Thombre, Avinash G.
    Thompson, Bruce
    Timko, Robert J.
    Upadrashta, Satyam
    Vaithiyalingam, Sivakumar
    AAPS PHARMSCITECH, 2014, 15 (03): : 665 - 693
  • [37] Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm
    Glenn A. Van Buskirk
    Satish Asotra
    Christopher Balducci
    Prabir Basu
    Gerald DiDonato
    Angelica Dorantes
    W. Mark Eickhoff
    Tapash Ghosh
    Mario A. González
    Theresa Henry
    Matthew Howard
    Jason Kamm
    Steven Laurenz
    Ryan MacKenzie
    Richard Mannion
    Patrick K. Noonan
    Terrance Ocheltree
    Umesh Pai
    Richard P. Poska
    Michael L. Putnam
    Ramani R. Raghavan
    Colleen Ruegger
    Eric Sánchez
    Vinod P. Shah
    Zezhi Jesse Shao
    Russell Somma
    Vijay Tammara
    Avinash G. Thombre
    Bruce Thompson
    Robert J. Timko
    Satyam Upadrashta
    Sivakumar Vaithiyalingam
    AAPS PharmSciTech, 2014, 15 : 665 - 693
  • [38] Psychedelic Drugs in the Post-Approval World: Important Components of Risk Evaluation and Mitigations Strategy (REMS) Programs to Protect Public Health While Ensuring Widespread Access
    Coe, Marion
    Ashworth, Judy
    Schnoll, Sid
    Henningfield, Jack
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 189 - 190
  • [39] Optic neuritis after mRNA vaccination against COVID-19: a secondary analysis of post-approval national safety data by the Japanese government
    Kaneda, Yudai
    Kawasaki, Chiharu
    Namba, Mira
    Kaneda, Uiri
    Ozaki, Akihiko
    Tanimoto, Tetsuya
    ANNALS OF EYE SCIENCE, 2023, 8
  • [40] Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality WorldwideJoint Position from EFPIA, IFPMA and Vaccines Europe
    Andrew Deavin
    Sarah Adam
    Susanne Ausborn
    Ane Sofie Böhm Nielsen
    Sonia Cappellini
    Isabelle Colmagne-Poulard
    Thierry Gastineau
    Arturo Gonzalez-Martinez
    Sylvie Meillerais
    Charlie Mortazavi
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 7 - 11
12345